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Abstract
The ability of pathogens to escape the host’s immune response is crucial for the establishment of persistent infections and
can influence virulence. Recombination has been observed to contribute to this process by generating novel genetic
variants. Although distinctive recombination patterns have been described in many viral pathogens, little is known about
the influence of biases in the recombination process itself relative to selective forces acting on newly formed recombinants.
Understanding these influences is important for determining how recombination contributes to pathogen genome and
proteome evolution. Most previous research on recombination-driven protein evolution has focused on relatively simple
proteins, usually in the context of directed evolution experiments. Here, we study recombination in the envelope gene of
HIV-1 between primary isolates belonging to subtypes that recombine naturally in the HIV/AIDS pandemic. By
characterizing the early steps in the generation of recombinants, we provide novel insights into the evolutionary forces that
shape recombination patterns within viral populations. Specifically, we show that the combined effects of mechanistic
processes that determine the locations of recombination breakpoints across the HIV-1 envelope gene, and purifying
selection acting against dysfunctional recombinants, can explain almost the entire distribution of breakpoints found within
this gene in nature. These constraints account for the surprising paucity of recombination breakpoints found in infected
individuals within this highly variable gene. Thus, the apparent randomness of HIV evolution via recombination may in fact
be relatively more predictable than anticipated. In addition, the dominance of purifying selection in localized areas of the
HIV genome defines regions where functional constraints on recombinants appear particularly strong, pointing to
vulnerable aspects of HIV biology.
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Introduction
Pathogens, and viruses in particular, are subject to strong
selective pressures during infection and often have characteristi-
cally high degrees of genetic variation [1]. Recombination is an
important evolutionary mechanism that contributes to this genetic
diversification. By creating novel combinations of pre-existing
genetic polymorphisms in a single replication cycle, recombination
enables greater movements through sequence space than can be
achieved by individual point mutations. As a consequence,
recombination provides access to evolutionary ‘‘shortcuts’’. In
addition, since recombination generally involves genes that
already encode functional products, the probability of producing
viable progeny is higher compared to the insertion of an equivalent
number of random point mutations [2]. However, the generation
of recombinant forms is not an unconstrained process. Genes and
genomes generally evolve through the slow accumulation of point
mutations, which often requires the progressive insertion of
compensatory mutations at ‘‘linked’’ sites. This coevolution
permits the preservation of epistatic interactions. By simultaneous-
ly introducing several substitutions, recombination has the
potential to substantially perturb such coevolved intra-genome
interaction networks [2,3], impairing the functionality of the genes
involved. Thus, the balance between the advantages of taking
evolutionary shortcuts and the risk of chimeras being dysfunctional
[2] determines the role played by recombination in the evolution
of a given gene or organism.
Several studies have focused on the impact of recombination on
the evolution of proteins, particularly in relation to directed
evolution experiments [4,5]. Two major factors have a large
influence on the functionality of recombinants proteins. The first is
the position of recombination breakpoint (the region where the
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sequence shifts from that of one parental sequence to the other)
relative to the location of genetic polymorphisms within the gene.
Recombinants involving a large number of non-synonymous
substitutions will in fact have a low probability of being functional
[2]. The second factor is the position of the breakpoints in relation
to the boundaries of discrete protein folds. Breakpoints near the
boundaries of these domains will in general have a smaller impact
on protein folding, and hence protein function, than breakpoints
occurring within them [3,6,7]. Recent work on Begomoviruses
corroborated these findings by demonstrating that recombination
events found in natural viral populations are significantly less
disruptive of protein folding than randomly generated recombi-
nants [8].
Adaptation of pathogens, either to on-going immune pressures
within individual hosts or following transmission to new hosts of the
same or different species, can result in infectious outbreaks that
constitute major threats for public health [9–12]. The human
immunodeficiency virus (HIV) is an extremely recombinogenic
pathogen in which recombination has been implicated in key
aspects of viral pathogenesis such as immune evasion [13],
transmissibility [14], the evolution of antiretroviral resistance
[15,16] and cross-species transmission [9,12]. Indeed, the remark-
able genetic flexibility of HIV is underlined by its large genetic
diversity. The HIV-1 population is subdivided into three groups,
named M, N and O, with group M (which is responsible for the vast
majority of the infections worldwide) being further subdivided into
nine subtypes (named A, B, C, D, F, G, H, J and K) [17].
Although recombination in HIV has been shown to occur at all
phylogenetic levels (intra- and inter-subtype, as well as inter-group,
reviewed in reference [18]), the most widely noted impact of
recombination on the genetic diversification of this virus is the
frequent natural occurrence of inter-subtype recombinants in parts
of the world where multiple subtypes co-circulate [19–22]. When
the same inter-subtype recombinant is transmitted between
multiple individuals, and has therefore the potential to be of
epidemiological significance, it is termed a Circulating Recombi-
nant Form (CRF) [17]. As with the HIV-1 subtypes, CRFs form
distinct clusters in phylogenetic trees and some of them contribute
substantially to the pandemic.
Sufficient inter-subtype recombinant sequences have been
sampled to permit the detailed characterisation of variation in
the locations of breakpoints both within individual genes [22,23],
and entire genomes [24,25,32]. This makes HIV a particularly
useful model for studying the forces that shape pathogen
populations within the context of global epidemics. Here we focus
on recombination within the envelope gene (env). This gene
encodes two polypeptides (gp120 and gp41) that form a
heterodimer at the surface of the viral particle. Trimers of these
heterodimers are the functional units that are responsible for
binding to the cellular receptors and co-receptors and ultimately
lead to viral entry into target cells [26]. The two protein products
of env are also the targets of all the neutralising antibodies
identified to date [27]. By using a tissue culture system to
characterise inter-subtype recombinants generated within env in
the absence of selection, and assaying the functionality of
recombinant genes, we produce an empirical model of HIV
recombination that accurately describes recombination patterns
found in viruses sampled throughout the HIV pandemic.
Results
Recombination pattern in the env gene
We used different combinations of env sequences from primary
HIV-1 isolates belonging to either different group M subtypes or
group O (see Materials and Methods for the list of parental isolates
used) to determine the distribution of breakpoints occurring within
the HIV env gene in the absence of selection. We chose
combinations of isolates belonging to subtypes that are co-
circulating in regions of the world from which natural inter-
subtype recombinant forms have emerged [28].
In order to quantify variations in recombination rates across env
we used a previously described experimental system where human
T cells are transduced with HIV-1 replication-defective vectors
pseudotyped with the Vesicular Stomatitis Virus (VSV) envelope
[29]. As this system mimics a single cycle of viral infection in which
reverse transcription products neither influence cellular survival,
nor confer a specific phenotype to the transduced cells,
recombinants that were produced during reverse transcription
were not subjected to any selection. After cloning of the reverse
transcription products in E. coli, the system enabled identification
of the recombinants based on the presence of a lacZ reporter gene
(Figure 1). Given that known input sequences were used, such an
approach enables the accurate and unambiguous localization of
the breakpoint position to precise regions bounded by nucleotides
that differ between the two parental sequences.
The regions of the envelope gene that were studied were chosen
so as to obtain 700 to 1,500 nucleotides overlapping windows,
spanning the whole of env. For each of seventeen different
combinations of parental sequence pairs (Figure 2A), a recombi-
nation rate per nucleotide and per reverse transcription run was
calculated within a 50 nucleotides sliding window (with 10
nucleotides step size). These were plotted as a function of the
location of the window along the gene. To evaluate whether
recombination-prone regions exist within the population, data
from the 17 different pairs of parental sequences were pooled and
an average recombination rate was computed for the different
regions, and plotted as function of the position along the env gene
(Figure 2B, top panel). Peaks and troughs were apparent all along
the gene, with regions refractory to recombination being more
Author Summary
Recombination allows mixing portions of genomes of
different origins, generating chimeric genes and genomes.
With respect to the random generation of new mutations, it
can lead to the simultaneous insertion of several substitu-
tions, introducing more drastic changes in the genome.
Furthermore, recombination is expected to yield a higher
proportion of functional products since it combines variants
that already exist in the population and that are therefore
compatible with the survival of the organism. However,
when recombination involves genetically distant strains, it
can be constrained by the necessity to retain the
functionality of the resulting products. In pathogens, which
are subjected to strong selective pressures, recombination
is particularly important, and several viruses, such as the
human immunodeficiency virus (HIV), readily recombine.
Here, we demonstrate the existence of preferential regions
for recombination in the HIV-1 envelope gene when
crossing sequences representative of strains observed to
recombine in vivo. Furthermore, some recombinants give a
decreased proportion of functional products. When consid-
ering these factors, one can retrace the history of most
natural HIV recombinants. Recombination in HIV appears
not so unpredictable, therefore, and the existence of
recombinants that frequently generate nonfunctional prod-
ucts highlights previously unappreciated limits of the
genetic flexibility of HIV.
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common in the gp120 coding portion than in the gp41 region. The
probability that breakpoints were more or less clustered across env
than could be accounted for by chance (given the null hypothesis
that breakpoint positions occur randomly) was determined by a
permutation test (Figure 2B, bottom panel). Six major recombi-
nation-prone or ‘‘hot’’ regions (shaded light blue areas in
Figure 2B) could be defined as env regions where breakpoint
clusters were bounded by statistically significant breakpoint ‘‘cold
spot’’ (p,0.05). Each of the six identified breakpoint clusters
contained at least one breakpoint cluster that constituted a
statistically significant recombination ‘‘hot-spot’’ (p,0.01). While
these recombination-prone regions covered only slightly more
than half of the whole gene (55.3%), they included 81.6% of all the
breakpoints (337/413) mapped. These six hot regions are areas
where recombination occurs preferentially during HIV replica-
tion, irrespective of the parental strains involved.
Selection for functional recombinants
We next investigated the fate of these recombinants with respect
to their establishment in the natural HIV-1 population. The
fixation of a recombinant gene within a population is dependent
on the interplay of multiple factors. Nevertheless, an obligatory
component of evolution is undoubtedly the elimination by
purifying selection of viruses that express dysfunctional proteins.
To evaluate how profoundly this aspect of natural selection might
influence the pattern of breakpoints generated by the mechanism
of recombination, we determined the relative functionality of a
subset of recombinant env genes.
In addition to encoding the proteins that coat the viral
membrane, env also encodes a well-known functional RNA
structure, the Rev responsive element (RRE). For the recombi-
nants containing breakpoints in the RRE region the functionality
of this RNA module was therefore also tested. Being involved in
the regulation of the timing and the balance among the various
forms of unspliced and partially or completely spliced RNAs, RRE
is essential for viral replication [30]. Failure to properly regulate
this process results in either a decrease or complete halt in viral
production [30]. The functionality of chimaeric RREs was tested
by measuring viral titres obtained upon transfection of cells with a
plasmid containing the proviral sequence of the molecular clone
NL4.3 of HIV-1, in which we had replaced the native NL4.3 RRE
with that of the various chimaeric RREs. To uncouple the effects
on RNA-folding caused by the introduced RRE sequences from
those altering the amino acid sequence of expressed proteins, we
used a variant of NL4.3 that does not express Env (NL4.3-Env2)
[31], and a plasmid encoding the wild-type Env was co-transfected
to complement the production of gp120 and gp41 proteins. In
order to increase the statistical power of the analysis, additional
chimaeric RREs were constructed using parental sequences other
than those employed in our cell culture recombinant generation
experiments (following a PCR procedure described in Materials
and Methods) and tested for their functionality. As can be seen in
Table 1, the viral titres obtained with every chimaeric RRE
sequence we tested were both similar to those obtained with non-
recombinant parental RRE sequences and markedly higher than
that observed when the RRE was replaced with a non-viral
sequence (see Materials and Methods). This result therefore clearly
indicated that recombinants generated by breakpoints within the
RRE generally retain the functionality of this element.
To determine the functionality of individual recombinant
envelopes at the protein level, full-length recombinant envelope
genes containing breakpoints of interest were constructed by
successive PCR, as described in Material and Methods. Each full-
length recombinant gene was then cloned in the pcDNA3.1
expression vector, and used to transfect HEK 293T cells together
with the pNL4.3-Env2-Luc plasmid, to generate viral particles
pseudotyped with the recombinant envelope of interest. The
functionality of the recombinant envelopes was then tested after
transduction of HEK 293T-CD4+-CCR5+ cells at a multiplicity of
infection of 0.1, by measuring luciferase expression in these cells
48 hours after transduction. Since target cells cannot synthesize
new viral envelope proteins, infection was limited to reverse
transcription and, potentially, integration. The luciferase values
observed therefore reflected the relative success of viral entry into
the target cells. For this analysis recombinants derived from
parental env sequences that yielded the strongest positive signals in
this single cycle test were chosen (parental sequences A-Q461, C-
CAP210, G-1033 and O-32, see Table 2 for their relative genetic
distance) due to the higher reliability of the luciferase signal. The
parental env sequences were used as controls. As for the functional
analysis of the RRE, additional recombinants involving combina-
tions of parental sequences – other than those involved in the
experiments of recombination in cell culture, but carrying
breakpoints in the same regions – were also tested. These
additional recombinant env sequences were generated by PCR,
as described for the reconstitution of the full-length env gene.
Luciferase values determined for each recombinant were plotted
as a function of the corresponding breakpoint position (Figure 3).
Recombinants with breakpoints falling within the six hot regions
indicated in Figure 2B were preferentially characterized. It was
apparent that most of the severely defective recombinants
contained breakpoints in hot regions 2 and 3 of the recombination
rate distribution (Figure 3). Given this data, we approximated a
probability of Env functionality being disrupted by breakpoints
falling within each of the six high recombination-rate regions.
Since the parental sequences themselves were not uniformly
functional (Figure 3), a situation that is probably common in
nature, for each recombinant an estimate of loss of functionality
was calculated by dividing the luciferase value obtained with that
recombinant by the one of the least functional parental sequence
involved in its generation. Recombinants displaying values
between those of the two parental sequences were considered to
Figure 1. Recombination during a single cycle of infection of
cells in culture. Schematic representation of the structure of the
genomic RNAs used for the recombination assay. White box at both
ends of the RNAs: R sequence; grey–black hatched box: U5 sequence;
white–grey hatched box: partially deleted and therefore non-functional
U3 sequence; white boxes: HIV envelope sequences studied, env X and
env Y stand for sequences of two different isolates (isolate X on the
donor RNA and isolate Y on the acceptor, respectively); black box:
marker lacZ’ bacterial gene; grey box: partial sequence of the bacterial
gene malT, inserted in the reverse orientation. The approximate
location of the BamHI site (present only on the donor RNA) and of
the PstI site present on both RNAs is also indicated. The path followed
by reverse transcription for generating the BamHI+/LacZ’+ recombinants
studied in the present work is indicated schematically.
doi:10.1371/journal.ppat.1000418.g001
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retain functionality (and assigned a functionality value of 1). Of
note, none of the recombinants yielded functionality values higher
than that of the most functional parent from which it was
generated. Values from recombinants containing breakpoints
within the same region of the six hot regions were pooled, and a
functionality loss value for each region was averaged (Figure 3).
The most significant loss of functionality was observed in regions
2, 3, and 6.
Natural recombination breakpoint distributions
essentially mirror those of the functional recombinants
generated in tissue culture
Having defined a pattern of recombination in the absence of
selection and the approximate probabilities of recombination events
in various parts of env yielding fully functional products, we were
interested in determining whether our experimental data could
explain breakpoint patterns observed in circulating recombinants.
The distribution along the whole HIV genome of 691 recombina-
tion breakpoints within HIV-1 group M full genome sequences
from the LANL HIV Sequence Databases (http://hiv-web.lanl.
gov/) was inferred. The same approach used in Figure 2B to define
the probability that at any region of the genome the breakpoints
were more clustered than would be expected by chance was used,
with a 200 nucleotides window. A previous analysis of HIV
recombinants modelled the distribution of breakpoints and
indicated a significant clustering of breakpoints in the 59 and 39
ends of the envelope gene and a lack of breakpoints between these
regions [32]. Our new analysis (Figure 4) confirmed the propensity
for breakpoints to be located at the 59 and 39 ends of the env gene
and the lack of breakpoints in the majority of its internal regions in
recombinants from the database.
In order to compare our experimentally determined breakpoint
distribution to that found in recombinants from the HIV Sequence
database, a higher-resolution view of the breakpoint distribution
within the env gene was determined using the positions of 133
unambiguously unique recombination breakpoints detectable
within 230 env sequences. Following the same procedure described
above, but using a 50 nucleotides window to enable detection of
breakpoint clusters at the same resolution as in our experimental
system, we identified a series of recombination hot- and cold-
regions within the gene (Figure 5A, purple graph). In a similar way
to the breakpoint distribution detected in cell culture, various hot
regions could be defined (light-purple boxes at the bottom of
Figure 5A), which corresponded remarkably well to recombination
hot regions 1, 5 and 6 seen in cell culture (light-blue boxes).
Whereas the other hot regions identified in cell culture had no
corresponding counterparts in the natural breakpoint distribution,
there was close correspondence between the cold-spots detected in
both distributions.
Next we used the SCHEMA-based method [8] to investigate
whether or not this breakpoint distribution exhibits evidence of
purifying selection acting on recombinants with disrupted protein
folding. This analysis indicated that breakpoints observable in
natural viruses tend to occur in regions within env that were
predicted to have a significantly lower impact on protein folding
than randomly placed breakpoints (p,1.061024 for gp120 and
p = 8.961023 for gp41, see Protocol S1). To investigate whether
accounting for variations in the functionality of recombinants might
reconcile the natural and experimental breakpoint distributions, we
first approximated the combined effects of mechanistic recombina-
tion rate variation (Figure 2B) and selection for fully functional
recombinants (Figure 3) on the distribution of breakpoints in cell
culture. Selection ‘‘corrected’’ recombination rate estimates were
then used to determine the distribution of 133 expected breakpoints.
The resulting distribution was used to evaluate the probability of
clustering of breakpoints (green graph in Figure 5A). Only regions 1,
4, 5 and 6 remained areas of significant clustering (light-green boxes
at the bottom of Figure 5A), a pattern very close to that found in
HIV recombinants sampled from nature, with the exception of
region 4 for which there was substantially less evidence of
recombination within natural recombinants than was expected
based on our empirical model. Indeed, when compared to the
Table 1. Functionality test of recombinant RRE structures.
Sample Name pg/ml of p24 Antigen Standard Deviation
RRE off DdNK 17 12
Parental A905 346 14
Parental G914 389 26
Parental O32 296 18
AG 1647 388 73
GA 1707 317 35
GA 1892 325 16
AG 1757 267 36
AG 1657 367 32
GA 1637 245 53
AG 1757 288 33
AC 7899 338 33
AC 7987 325 27
GB 7935 283 15
GC 7935 301 43
OG 7810 318 12
OG 8090 234 45
doi:10.1371/journal.ppat.1000418.t001
Figure 2. Recombination breakpoint distributions determined in a selection-free experimental setting. (A) Recombination pattern
along the env gene with the different pairs of isolates studied. Recombination rates per nucleotide observed after a single infection cycle are plotted
as a function of the position along the env gene, as indicated in the example of the 914G/899A pair, given in the insert (the identity of the parental
isolates is given as donor/acceptor). Nucleotide positions are given, throughout the article, in relation to the position on the HXB2 isolate genome.
Recombinants 115A/126D, 115A/89D, 120A/89D, and 126D/120A were described previously [33]. The number (n) of individual recombinants for
which the position of the breakpoint has been mapped is given on the right of each graph. A map of gp120 and gp41 domains is given as a frame of
reference at the top of the figure. (B) top graph: pooled distribution of recombination breakpoints across env, obtained as described in Materials and
Methods. Bottom graph: the height of the black plot at any particular position represents the probability (determined by a permutation test with
10,000 iterations) that recombination breakpoint distributions are not more clustered than would be expected by chance within a 50 nucleotides
window centred on that position. Assuming that breakpoints are randomly distributed, the dark and light grey regions represent degrees of
breakpoint clustering expected due to chance in 95% and 99% of the examined windows, respectively. Whereas peaks emerging above the grey
regions represent possible recombination hot-spots, troughs dipping below the grey regions represent possible recombination cold-spots. The pale-
blue shaded areas numbered from 1 to 6 correspond to breakpoint clusters, or hot regions, as defined in the text.
doi:10.1371/journal.ppat.1000418.g002
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distribution found for the 133 breakpoints encountered in the
natural HIV recombinants (Figure 5B), a remarkable overlap was
observed, with the discrete statistically significant breakpoint
clusters being consistently recaptured by our empirical model of
env recombination. The substantial difference of recombination
rates in region 4 was also clear.
Discussion
Through the functional characterization of HIV envelope genes
generated by recombination in the absence of selection, we retrace
the early steps shaping patterns of inter-subtype env recombination
found in the HIV-1 pandemic. We observe that the mechanism of
recombination alone defines regions where recombination occurs
at significantly higher rates than elsewhere along the gene. The
existence of such regions is strongly suggestive of spatially
conserved features in HIV genomes that either promote or restrict
recombination between different isolates. The distribution of
breakpoints within the gp120 encoding region (Figure 2B) is likely
due to the distribution of conserved and variable regions, the latter
restricting recombination because of the low degree of local
sequence identity between the parental sequences [32,33].
Within genomic regions where sequence identity is high, a
trigger for recombination could be the presence of secondary
Figure 3. Functionality of recombinant envelope proteins. Functionality of the recombinant proteins as a function of the breakpoint position
(in nucleotides) along the env gene. Each individual recombinant tested is indicated by a circle. Error bars indicate standard deviations observed in
four independent experiments. The luciferase values that were determined for the four parental strains used to generate the recombinants are
represented, as a frame of reference, by lilac bars on the right. The six recombination-prone regions defined in Figure 2B are shaded in pale blue and
annotated accordingly above the graph. The value of loss of functionality approximated for each region is given in bold in the top part of the graph.
Three M/O inter-type recombinants were also tested (AO456, AO7810, and AO8090, breakpoint positions 6508, 7810, and 8090, respectively, of the
HXB2 reference strain), resulting in a complete loss of functionality, probably due to the higher sequence divergence between the parental isolates. In
order to preserve the homogeneity of the dataset to intersubtype recombinants, these recombinants are neither presented in the figure, nor were
considered for the calculation of the average functionality of the recombinants, described in the main text.
doi:10.1371/journal.ppat.1000418.g003
Table 2. Identity between different pairs of parental sequences.
A-Q461
(2598 nt)
B-THRO
(2622 nt)
C-CAP210
(2595 nt)
G-1033
(2577 nt)
O-32
(2619 nt)
HXB2
(2568 nt)
A-Q461 — 0.721 0.744 0.734 0.510 0.718
B-THRO 0.782 — 0.710 0.698 0.491 0.798
C-CAP210 0.796 0.772 — 0.726 0.501 0.711
G-1033 0.800 0.77 0.787 — 0.507 0.713
O-32 0.581 0.564 0.578 0.581 — 0.486
HXB2 0.792 0.870 0.784 0.790 0.574 —
Regular text gives the level of identity at the nucleotide level, bold text at the amino acid level.
doi:10.1371/journal.ppat.1000418.t002
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structures [34]. The highest recombination peak within the second
region in Figure 2B (corresponding with the C2 portion of gp120)
coincides with a recombination hot-spot that is determined by the
presence of a stable RNA hairpin structure [29,35,36], while the
fourth hot region (Figure 2B) corresponds to the RRE RNA
structure that is highly conserved amongst all HIV isolates [37]. It
is therefore possible that RNA secondary structures also contribute
to the high rates of recombination observed at some of the other
recombination hot regions. Noteworthy, the functionality of the
RRE was retained even when crossing genetically distant isolates
as for inter-group M/O recombinants (Figure 2A), supporting the
possibility that regions of the genome harbouring functional RNA
structures, which are generally more conserved within the
population, provide a mechanism for crossing distantly related
retroviruses and are possibly important for recombination of RNA
viruses in general.
With respect to selection of recombinant genes at the protein
level, experiments involving lattice proteins have shown that genes
encoding proteins that tolerate mutations also tend to be
recombination tolerant [2]. Since the env gene displays a degree
of diversity between isolates from different HIV-1 group M
subtypes ([38] and references herein) that is two to three times
higher than the genome average, we anticipated that the manifest
mutation tolerance of env might predispose it to high recombina-
tion tolerance. However, we show that this is not the case with
certain regions within the gp120 encoding portions of env
(particularly region 2 described in the present work in Figure 3)
tending not to tolerate recombination well.
Viruses with small genomes (including all RNA viruses) tend to
use overlapping genes expressed in different reading frames and to
encode proteins that have multiple functions. The HIV envelope
encodes for such proteins [26], and the subtle biochemical
equilibrium that regulates their functionality is very possibly
limiting tolerance to recombination. The low recombination
tolerance of the gp120-encoding region could only be imprecisely
predicted based on computational estimates of recombination
induced protein fold disruption using the SCHEMA algorithm [3].
This may have been due to either our SCHEMA analyses being
based on incomplete gp41 and gp120 structures or the fact that the
structures used only reflected a single conformation of these two
proteins. Therefore this analysis neither takes into account the
conformational changes required for Env functionality, nor the
quaternary arrangement of the proteins within Env trimers.
Despite these issues, the SCHEMA analysis indicated that,
amongst the HIV env sequences sampled from nature, selection
has been acting against recombinants with disrupted protein
folding (Table S1). Unravelling the molecular reasons for the
reduced functionality of certain recombinants could provide
valuable insights into the nature of the molecular interaction
networks required for proper Env function.
The specific determinants of viral fitness (or in vivo replicative
capacity) are complex and poorly understood at present. The
fixation of a recombinant gene within a population is likely to
depend on the interplay of multiple factors. Although combining
cell culture functionality data with recombination rate heteroge-
neity is an oversimplified view of this process, the pattern of
recombination predicted by our empirical model matches
remarkably well the breakpoint distributions observed in nature
(Figure 5B). The only major deviation from this was constituted by
the fourth recombination hot region observed in cell culture,
which was absent from the natural breakpoint distribution
(Figures 2B and 5B). Determining the reasons for this discrepancy
will improve our understanding of the mechanisms governing the
success of recombinants in nature.
Although the host immune response certainly plays a significant
role in the selection of recombinant variants in vivo [13], the
similarities between the natural and experimental breakpoint
distributions suggest that the forces responsible for the selection of
recombinants in vivo only have limited impact on inter-subtype
breakpoint patterns in env. This is most likely due to a combination
of factors including mainly the complex epistatic interactions
within env, the high density of fitness-determining loci within this
gene, and the biochemical mechanism of recombination, which
collectively constrain the fixation of genetic variability introduced
by recombination. Negative fitness effects associated with
recombination in env, however, should decrease with decreasing
parental genetic distances [3,6,39] and therefore, in the context of
intra-subtype recombination, the selective constraints on recom-
binants should be more relaxed than we have found them to be
here.
Considering recombination in env in the context of the rest of
the HIV genome, it is apparent that env displays the most
dramatically variable natural breakpoint distribution of all HIV
genes [24,32], and it constitutes the only gene within which there
Figure 4. Natural recombination patterns across the HIV genome. The representation is the same as for the bottom panel of Figure 2B. The
row of vertical lines above the plot represents the inferred positions of the 691 breakpoints used in its construction. The genome map of the HXB2
HIV-1 group M strain is given as a frame of reference.
doi:10.1371/journal.ppat.1000418.g004
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Figure 5. Natural recombination breakpoint distributions can be essentially accounted for by a combination of mechanistic
recombination rate variations and selection against dysfunctional recombinants. (A) The recombination breakpoint distribution
detectable using HIV 1 group M env genes sampled from nature (purple) and in cell culture after correction for the functionality of the recombinant
products (green). The representations are the same as for the bottom panel of Figure 2B. Boxes at the bottom of the figure define the hot
recombination regions (as defined in the text) identified in cell culture, amongst natural HIV recombinants, and in cell culture after correction for the
functionality of the recombinants. Darker boxes indicate statistically significant hot-spots where breakpoints are particularly tightly clustered
(p,0.01). A map of gp120 and gp41 domains is given as a frame of reference at the top of the panel. (B) The purple plot represents the distribution of
breakpoints observed in natural HIV recombinants and the green plot the mean expected distribution based on our empirical model formulated
using ‘‘functionality correction’’ of our breakpoint distributions determined in cell culture. Regions outside the recombination hot regions shown by
the boxes in the lower portion of (A) of the figure are shaded.
doi:10.1371/journal.ppat.1000418.g005
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is an extended region with limited recombination (Figure 4).
Nevertheless, although less marked, breakpoint distribution
patterns reminiscent of those found in env, with alternate clusters
and troughs are also identifiable in several other regions of the
genome such as gag and pol [32] (Figure 4). Although little
information is presently available either on differential mechanistic
predispositions to recombination across these regions, or on the
functionality of the resulting products, it is tempting to speculate
that underlying rules such as we have defined here for env may also
be operational in these other cases.
In conclusion, by experimentally reproducing the generation of
HIV-1 recombinants, we demonstrate that the distinctive
distribution of breakpoints found in natural viruses is strongly
shaped by both the mechanism of recombination, and the relative
functionality of the recombinant genes. Thus, HIV evolution
might not be the relentlessly unpredictable process it sometimes
seems, and exploiting this evidence to pre-empt and counter the
most favoured evolutionary tactics of this virus may ultimately be
an efficient means by which we can devise effective vaccines and
improve drugs against the virus.
Materials and Methods
Cell culture
HEK 293T, and CD4+CCR5+ 293T cells were grown in
Dulbecco’s modified Eagle’s medium supplemented with 10%
foetal calf serum, penicillin, and streptomycin (from Invitrogen,
CA, USA), and maintained at 37uC with 10% CO2. MT4 cells
were maintained in RPMI 1640 medium supplemented with 10%
foetal calf serum and antibiotics at 37uC with 5% CO2.
Viral sequences
The parental isolates used in this study were A-115, A-120, A-
899 [33], A-859, A-905 (from S. Saragosti) and A-Q461 (Gene
Bank: AF407156) for subtype A isolates; B-THRO (Gene Bank:
AY835448), for subtype B; D-126, D-89, D-122, [33] and D-21.16
(Gene Bank: U27399), for subtype D; C-CAP210 (Gene Bank:
DQ435683), for subtype C; G-858, G-914, (from S. Saragosti) and
G-MP1033 (from M. Peeters, Gene Bank: AM279365), for
subtype G; O-35 and O-32, for group O (from S. Saragosti).
Single cycle tissue culture recombination assay
Single cycle recombination assays were performed using a
system previously developed by our laboratory [29]. HIV-1 env
fragments from group M subtypes A, C, D and G, and from group
O viral DNA were amplified by PCR from infected PBMCs
obtained from patients and cloned in plasmids (called genomic
plasmids), which differ for the genetic marker present downstream
(in the sense of reverse transcription) of the sequence in which
recombination is studied (Figure 1). All constructs were verified by
sequencing. The trans-complementation plasmids, pCMV R8.2
[40] encoding HIV-1 Gag, Pol, and accessory proteins, and
pHCMV-G [41] encoding the Vesicular Stomatitis Virus envelope
protein were co-transfected into 293T cells with the two genomic
plasmids to produce defective retrovirus particles which were then
used to transduce MT4 cells as previously described [29]. The
reverse transcription products were purified from the cytoplasmic
fraction of transduced cells using the method described by Hirt
[42]. The purified double stranded DNA was digested with DpnI
for 2 h at 37uC (in order to eliminate possible contaminating DNA
of bacterial origin) prior to PCR amplification as previously
described [29]. The amplified product was purified after
electrophoresis on agarose gel, digested with PstI and BamHI,
ligated to an appropriate plasmid vector and used to transform E.
coli. Plating on IPTG/X-Gal containing agar plates allowed blue/
white screening of recombinant and parental colonies, respectively
[29]. The frequency of recombination was determined by
computing the number of blue colonies over the total number of
colonies as described in reference [29]. Recombination break-
points were identified by full-length sequencing of the env portion
of the recombinant clones.
Analysis of recombinants generated after a single
infectious cycle in tissue culture
The recombinant and parental sequences of each pair of isolates
tested were aligned using CLUSTAL X [43]. The breakpoint
location of each recombinant was determined as being the central
position of the interval bounded by the two closest nucleotide sites
that were characteristic of each of the parental sequences).
Recombination rates were calculated as follows. We define each
recombination window studied with each pair of parental
sequences as RwXYa–b, for a recombination window involving
isolates X and Y, spanning position a to position b of env (reference
sequence HXB2); a 50 nucleotides window was then considered
(XYa–bSwi, for a sliding window starting at position i of env),
beginning from the 59 border of the sequence studied and the
number of breakpoints (indicated as XYa–bni) falling within the
window was counted. The resulting recombination rate per
nucleotide in the sliding window XYa–bSwi is
XYa{bRi~F XYa{bni=XYa{bNð Þ=50
where XYa–bN is the total number of breakpoints characterized for
the RWXYa–b pair, and 50 is the size in nucleotides of the sliding
window, and F the frequency of recombination observed in the
whole region studied, as defined in the previous chapter. The sliding
window was then displaced with a 10 nucleotides increment
(resulting in XYa–bSwi+10, XYa–bSwi+20, … ) across the recombination
window, and XYa–bRi+10, XYa–bRi+20, … were computed. The
various R values were reported in the graph as a function of the
position of the midpoint of the window along the gene (i.e. the
position of the 25th nucleotide of each sliding window). For the
pooled dataset reported in Figure 2B, the analysis based on the
sliding window was repeated. If Swpi stands for the sliding window at
position i for the pooled dataset, Rpi for the corresponding
recombination rate, and q is the number of recombination window
including position i, recombination rate at position i is calculated as
Rpi~ XYa{bRizX1Y1a1{b1Riz . . .zXqYqaq{bqRi
 
q
To statistically test for the presence of recombination hot and cold-
spots in the experimentally determined recombination breakpoint
distributions we used a modification of a permutation test described
previously [44]. Unlike in analyses of natural recombinants, the
breakpoint positions approximated in our experimental procedure
were not subject to biases introduced by underlying degrees of
parental sequence nucleotide variability and patchiness of parental
sequence sampling. Rather than explicitly accounting for these
biases when placing randomised recombination breakpoints as in
the permutation test described by Heath et al. [44], our
modification of the test involved the completely randomised
placement of recombination breakpoints. The test essentially
involved the randomised recreation of 10,000 versions of our real
dataset with each version containing exactly the same number of
breakpoints between the same 17 parental sequence pairs observed
in the real dataset. From breakpoint distributions determined for
each of these 10,000 randomised datasets we were able to work out
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confidence intervals for expected breakpoint density variation given
the completely random occurrence of recombination.
For simulating the distribution of 133 breakpoints based on the
combined effects of (i) the mechanistic recombination rate and (ii)
selection for functional recombinants, local recombination rate
data used to generate the graph in Figure 2B were first multiplied
by the respective functionality scores given in Figure 3 for each
corresponding region, yielding ‘‘functionality corrected’’ rates for
each region. Once the expected breakpoint distribution of 133
unique recombinants determined by this method, the number of
breakpoints present in a 50 nucleotides rolling window, sliding
with a 10 nucleotides increment was calculated and plotted (in
Figure 5B) as function of the position along the gene. Deviations
from expected degrees of breakpoint clustering given the null
hypothesis of random breakpoint locations, was tested using the
same modification of the Heath et al., [44] permutation test
detailed above.
Construction of full-length recombinant envelope genes,
and recombinant RREs by PCR
Full-length sequences of recombinant env genes were reconsti-
tuted, using an overlapping PCR procedure. We separately
amplified the region from the 59 end of the acceptor gene (using
primer Topo59 annealing to positions 5966–5990 of the reference
strain HXB2) to the breakpoint position (using a specific primer
encompassing the region of the breakpoint) and from the 39 end of
the donor gene (primer Donor39, HXB2 positions 8785–8819) to
the breakpoint position (also in this case with a specific primer).
These PCR products, overlapping by approximately 30 nucleo-
tides around the breakpoint site, were mixed at equal ratios and
used as templates to generate the full-length recombinant env gene
using primer Topo59 and Donor39. All PCR reactions were run
with Phusion DNA polymerase (Finnzymes, Finland) for 30 cycles.
PCR products were gel purified and ligated to pCDNA3.1 Topo
(Invitrogen, CA, USA). For RRE functionality assays, a portion of
the envelope gene containing the RRE of pNL4.3-Env2-Luc
(nucleotides 7646 to 8046) was replaced with the corresponding
sequence of parental or recombinant envelope genes or, as a
negative control, a 400 nt sequence from the Drosophila melanogaster
desoxynucleoside kinase gene (DdNK). All constructs were verified
by sequencing.
Functionality of RRE sequences
HIV particles were produced by co-transfection of HEK 293T
cells with an expression vector for a CCR5-tropic (ADA) HIV-1
envelope [45] kind gift of Dr. M. Alizon, together with a pNL4.3-
Env2-Luc containing either a parental or recombinant RRE
sequence or DdNK. Forty-eight hours post transfection, superna-
tants were filtered trough a 0.45 mM filter and p24 levels were
determined using the HIV-1 p24 enzyme-linked immunoabsor-
bent assay kit (PerkinElmer Life Sciences, MA, USA).
Functionality of Env proteins
Reporter HIV-1 particles were produced by co-transfection of
HEK 293T cells with pNL4.3-Env2-Luc and either an empty
expression vector or an expression vector encoding either a
parental or a recombinant env. For each individual recombinant
variant, prior to their use for transfection, clones were verified by
sequencing of the region encoding the recombinant gene as well as
the vector-encoded promoter for its expression. Supernatants,
containing virus stock, were harvested 48 h post transfection, and
filtered trough a 0.45 mM filter. Production of viral particles was
tested using an enzyme linked immunoassay for HIV-p24 antigen
detection (Perkin Elmer, MA, USA) and 20 ng of p24 were used to
infect 105 293T CD4+-CCR5+ cells in 24 wells plates. Forty-eight
hours later, cells were washed twice in PBS and lysed in 25 mM
Tris phosphate, pH 7.8, 8 mM MgCl2, 1 mM dithiothreitol, 1%
triton X-100, and 7% glycerol for 10 min in a shaker at room
temperature. The lysates were centrifuged and the supernatant
was used to measure luciferase activity using a GloMax 96
Microplate Luminometer (Promega, WI, USA) following the
instruction of the luciferase assay kit (Promega, WI, USA). For
samples that yielded negative results in the luciferase assay,
plasmids from at least three independent bacterial clones were
tested.
Recombination analysis of sequences sampled from
nature
The HIV-1 group M envelope sequence alignment was
retrieved from the Los Alamos National Laboratory (LANL)
HIV Sequence Database (http://hiv-web.lanl.gov/). The align-
ment was reduced to subtype reference sequences (3 strains for
each where available), 53 CRF strains (2 strains for each where
available) and finally 197 apparently unique recombinants.
Recombination was analyzed using the RDP [46], GENECONV
[47], BOOTSCAN [48], MAXCHI [49], CHIMAERA [50],
SISCAN [51], and 3SEQ [52] methods implemented in the
program RDP3BETA30 [53]. Default settings were used throughout
except that: (1) only potential recombination events detected by
four or more of the above methods, coupled with phylogenetic
evidence of recombination were considered significant; (2)
sequences were treated as linear; and (3) a window size of 30
variable nucleotide positions was used for the RDP method. Using
the approach outlined in the RDP3 program manual (http://
darwin.uvigo.es/rdp/rdp.html), the approximate breakpoint posi-
tions and recombinant sequence(s) inferred for every potential
recombination event, were manually checked and adjusted where
necessary using the phylogenetic and recombination signal analysis
features available in RDP3. Breakpoint positions were classified as
unknown if they were (1) detected at the 59 and 39 ends of the
alignment but could have actually fallen outside the analysed
region; or (2) within 20 variable nucleotide positions or 100 total
nucleotides of another detected breakpoint within the same
sequence (in such cases it could not be discounted that the actual
breakpoint might not have simply been lost due to a more recent
recombination event). All of the remaining breakpoint positions
were manually checked and adjusted when necessary using mainly
the MAXCHI and 3SEQ methods (using three sequence scans
and the MAXCHI matrix method) but also the LARD matrix
method (generated by the LARD two breakpoint scan; [54]), and
the CHIMAERA method as tie breakers. The distribution of
unambiguously detected breakpoint positions of all unique
recombination events were analysed for evidence of recombination
hot- and cold-spots with RDP3 as described by Heath et al. ([44]; a
window size of either 50 or 200 nucleotides and 10 000
permutations). A normalised version of the breakpoint distribution
plot described in that study was used in which the local probability
values of breakpoint numbers (determined by a permutation test
that takes into account that local degrees of sequence diversity
influence the delectability of recombination events) were plotted
instead of absolute breakpoint numbers.
Schema analysis
PDB files detailing the three dimensional structures of both
gp120 (PDB ID: 2B4C, determined by X-ray diffraction,
resolution of 3.3 A˚, 338 amino acids, [55]), and gp41 (PDB ID
1AIK, determined by X-ray diffraction, resolution of 2 A˚, 70
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amino acids, [56]) were obtained from http://www.rcsb.org. It is
important to point out that these structures are partial and that we
therefore only analysed a fraction of the structural interactions
involved in Env folding. We performed SCHEMA predictions of
recombination induced fold disruptions using the set of natural
HIV env recombinants (described above) essentially as described in
Lefeuvre et al. ([8]; See Protocol S1, Supplementary Analyses, for
a description of the SCHEMA method). This involved: (1)
computing protein fold disruption, or E, scores for each natural
recombinant with identifiable parents; (2) based on every pair of
parental sequences identified for the observed set of recombinants,
simulating every possible recombinant that could have been
produced with these parental sequence pairs that involved the
exchange of the same number of non-synonymous polymorphisms
as were exchanged during the actual recombination events; (3)
calculating E scores for each of these simulated recombinants; and
(4) using a permutation test to determine whether mean E scores
calculated for the natural recombinants were significantly lower
than mean E-scores for the same set of recombinants randomly
drawn from the simulated recombinant datasets (Table S1). If
fewer than 5% of simulated datasets had an average E score lower
than that of the actual dataset (p,0.05) then this was taken to
indicate that predicted fold disruptions incurred by real events
were significantly less severe than if the observed distribution of
breakpoints was uninfluenced by negative selection acting against
recombinants with disrupted protein folding.
Supporting Information
Protocol S1 Supplementary analyses. Schema analysis on the
HIV envelope gene.
Found at: doi:10.1371/journal.ppat.1000418.s001 (0.02 MB
DOC)
Table S1 Mutation and disruption value for gp41 and gp120
datasets real and simulated recombination events.
Found at: doi:10.1371/journal.ppat.1000418.s002 (0.04 MB
DOC)
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